HAMILTON, BM / ACCESS Newswire / July 15, 2025 / Altamira Therapeutics Ltd. ("Altamira" or the "Company") (OTCQB:CYTOF), a company dedicated to developing therapeutics that address important unmet med ...

As of May 2023, the WHO recommends the use of a monovalent XBB.1 descendent lineage, such as omicron XBB.1.5, as the vaccine antigen for COVID-19 vaccines. However, BA.2.86 and its descendent lineages ...

Moderna says mRNA flu vaccine sailed through trial, beating standard shot Moderna hailed the results, but the shot's future under RFK Jr. is murky.

Scientists at Tel Aviv University and the Israel Institute for Biological Research have developed the first mRNA vaccine proven completely effective against deadly bacteria. This groundbreaking ...

The long and winding journey of Moderna’s mRNA flu vaccine toward regulators has come one step closer with a phase 3 win over an approved competitor.

In the improved method, they used DNA and mRNA that are of equal length. "The use of equal-length DNAs and mRNAs allowed us to create pools containing diverse proteins with a wide range of sizes ...

Morabaha Marina Financing Co.’s (MRNA) board of directors reappointed Mohammed Al-Ghumlas as Chairman, and Salman Al-Asmari as Vice Chairman. For more news on listed companies In a statement to ...

The latest trading day saw Moderna (MRNA) settling at $33.64, representing a -1.87% change from its previous close.

HAMILTON, BM / ACCESS Newswire / July 15, 2025 / Altamira Therapeutics Ltd. ("Altamira" or the "Company") (OTCQB:CYTOF), a company dedicated to developing therapeutics that address important unmet ...

Israeli researchers have developed the world’s first vaccine against a deadly bacterium, utilizing the same system used to combat COVID-19, according to a joint statement from Tel Aviv ...